I doubt we will see any sort of recovery until guidance is provided for the 1H. I am expecting the 1H result to be much stronger than last years.
At this price it is pretty enticing.
H1 revenues will be interesting - first time for a while we'll be comparing apples with apples. There won't be inflated headline % growth numbers inflated because of things like first full half year of CS Con etc
It'll be all down to body care stuff, CS might be marginally ahead and candles will dilute growth in the other areas
Last edited by winner69; 24-06-2017 at 03:49 PM.
“ At the top of every bubble, everyone is convinced it's not yet a bubble.”
Bookmarks